1
|
Chao S, Liu Y, Ding N, Lin Y, Wang Q, Tan J, Li W, Zheng Y, Hu X, Li J. Highly Expressed Soluble Recombinant Anti-GFP VHHs in Escherichia coli via Optimized Signal Peptides, Strains, and Inducers. Front Mol Biosci 2022; 9:848829. [PMID: 35359590 PMCID: PMC8960375 DOI: 10.3389/fmolb.2022.848829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 01/31/2022] [Indexed: 11/13/2022] Open
Abstract
Antigen-binding variable domains of the H chain of heavy-chain antibodies (VHHs), also known as nanobodies (Nbs), are of great interest in imaging technique, disease prevention, diagnosis, and therapy. High-level expression of soluble Nbs is very important for its industrial production. In this study, we optimized the expression system of anti-green fluorescent protein (GFP) VHHs with three different signal peptides (SPs), outer-membrane protein A (OmpA), pectate lyase B (PelB), and L-asparaginase II SP (L-AsPsII), in different Escherichia coli strains via isopropyl β-D-thiogalactoside (IPTG) induction and auto-induction, respectively. The solubility of recombinant anti-GFP VHHs with PelB or OmpA was significantly enhanced to the same extent by IPTG induction and auto-induction in BL21 (DE3) E. coli strain and the maximum yield of target protein reached approximately 0.4 mg/l in a shake flask. The binding activity of recombinant anti-GFP VHHs was also confirmed to be retained by native-polyacrylamide gel electrophoresis (PAGE). These results suggest that SPs like OmpA and PelB could efficiently improve the recombinant anti-GFP VHH solubility without changing its bioactivity, providing a novel strategy to optimize the E. coli expression system of soluble VHHs, and lay the foundation for the industrial production of soluble recombinant anti-GFP VHHs and the research of other VHHs in the future.
Collapse
Affiliation(s)
- Shuangying Chao
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Yuhang Liu
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Ning Ding
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Yue Lin
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Qian Wang
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Junwen Tan
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Wei Li
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
| | - Yang Zheng
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
- *Correspondence: Yang Zheng, ; Xuejun Hu, ; Junming Li,
| | - Xuejun Hu
- Medical College, Dalian University, Dalian, China
- DalianKey Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China
- *Correspondence: Yang Zheng, ; Xuejun Hu, ; Junming Li,
| | - Junming Li
- Department of Clinical Laboratory, Yantai Yuhuangding Hospital, Yantai, China
- *Correspondence: Yang Zheng, ; Xuejun Hu, ; Junming Li,
| |
Collapse
|